News
Spotlight on European ETFs Ahead of Expected BoE December Rate Cut
Anticipation is mounting among financial experts as the Bank of England (BoE) is widely expected to cut interest rates at its December meeting. According to a Reuters poll conducted in November
VinFast Auto Ltd. (VFS) Reports Q3 Loss, Lags Revenue Estimates
VinFast Auto Ltd. (VFS) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago. These figures
US Approves $93M Weapon Sale to India: A Boost for Defense ETFs
In a significant boost to U.S.-India strategic ties, the United States has officially approved $93 million in weapon sales to India, covering the supply of up to 100 Javelin anti-tank missiles and
NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth
Novartis NVS recently held an investor event, wherein management projected sales to grow at a compounded annual growth rate (CAGR) of 5-6% (at constant currencies) for 2025-2030.
Management also
AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo
AstraZeneca AZN announced that the FDA has approved its oral, selective MEK inhibitor, Koselugo (selumetinib), for expanded use. The drug is now indicated to treat symptomatic, inoperable plexiform
Are Options Traders Betting on a Big Move in Ameriprise Financial Stock?
Investors in Ameriprise Financial, Inc. AMP need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $270 Call had some of the highest
Implied Volatility Surging for Associated Banc-Corp Stock Options
Investors in Associated Banc-Corp ASB need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $5 Call had some of the highest implied
Intuit Q1 Earnings Surpass Estimates, Online Ecosystem Revenues Surge
Intuit INTU reported first-quarter fiscal 2026 non-GAAP earnings per share (EPS) of $3.34, which beat the Zacks Consensus Estimate of $3.10. The bottom line jumped 33.6% from the year-ago
Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High?
Shares of Tango Therapeutics, Inc. (TNGX) have gained 18.2% over the past four weeks to close the last trading session at $8.9, but there could still be a solid upside left in the stock if
Wall Street Analysts Believe Palomar (PLMR) Could Rally 27.95%: Here's is How to Trade
Palomar (PLMR) closed the last trading session at $121.66, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Western Digital (WDC) Could Rally 25.25%: Here's is How to Trade
Western Digital (WDC) closed the last trading session at $140.23, gaining 11.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does Sandisk Corporation (SNDK) Have the Potential to Rally 33.98% as Wall Street Analysts Expect?
Shares of Sandisk Corporation (SNDK) have gained 17.3% over the past four weeks to close the last trading session at $195.96, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade
Shares of Enanta Pharmaceuticals (ENTA) have gained 13.7% over the past four weeks to close the last trading session at $12.13, but there could still be a solid upside left in the stock if
Qualys (QLYS)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Qualys, Inc. (QLYS) could be a good stock pick from a technical perspective. QLYS recently experienced a "golden cross" event, which saw its 50-day simple
Wall Street Analysts Think TTM (TTMI) Could Surge 30.03%: Read This Before Placing a Bet
TTM Technologies (TTMI) closed the last trading session at $58.45, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
ITRI Boosts Resiliency Solutions Portfolio With $525M Locusview Buyout
Itron, Inc. (ITRI) recently inked a definitive agreement to acquire Locusview, Ltd. and subsidiaries (Locusview), a privately held software-and-services provider focused on utility construction
EPD to Generate Additional Cash Flows From $5B Project Backlog
Enterprise Products Partners LP EPD is a leading midstream player that generates stable cash flows and is not highly vulnerable to the volatility in oil and natural gas prices. The partnership has a
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Why Markel Group (MKL) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Eli Lilly (LLY) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research


